FDA · United States
methimazole — FDA regulatory status
methimazole (METHIMAZOLE) regulatory status in the United States is tracked from public FDA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: FDA approved.
Status snapshot
- Status
- FDA approved
- Brand
- METHIMAZOLE
- Originator
- Disc Medicine
- Mechanism
- Thyroid peroxidase inhibitor
- Target
- Thyroid peroxidase
- Structured fields
- 8
Sponsor / originator context: Disc Medicine. Pipeline programs and exclusivity signals below are joined from ClinicalTrials.gov-linked projects and USPTO/EPO patent rows associated with this INN.
Pharmacology context used for competitive intelligence: Thyroid peroxidase inhibitor. Target: Thyroid peroxidase. This page is a status aggregation for professional reference — not prescribing advice.
Regional decision snapshot — FDA: approved.
Linked evidence on this spoke: 2 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| FDA | United States | approved | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| Sodio ioduro (I131) Curium Netherlands 37-740... | Phase 3 | Sana Biotechnology | 2024-518452-23-00 |
| Methimazole | Approved | First People's Hospital | NCT05461820 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 12420085 | Synergistic therapies for inter vertebral disc degeneration | US |
| 12403069 | Adapter for use in a planetary mixer | US |
| 12396924 | Adapter for use in a planetary mixer | US |
| 12390497 | Microbial strains for virus inhibition | US |
| 12357702 | Peptidic diagnostic compositions | US |
| 12351590 | Pyrrolopyrimidine compound and use thereof | US |
| 12338218 | Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of solvate thereof, and preparation method thereof | US |
| 12319684 | Agonists of the apelin receptor and methods of use thereof | US |
| 12312357 | PRMT5 inhibiting compounds and uses thereof | US |
| 12295909 | Adapter for use in a planetary mixer | US |
| 12290569 | Methods and compositions using peptides and proteins with c-terminal elements | US |
| 12285392 | Method for modulating metabolism | US |
Related hubs
FAQ
What is the FDA approval status of methimazole?
methimazole currently shows FDA approved in our United States regulatory index. Confirm on the official FDA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get methimazole regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to methimazole?
This spoke lists 2 published programs associated with methimazole in our pipeline index.